Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniela Valpiani"'
Autor:
Marcello Galvani, Miriam Compagnone, Fabio Tarantino, Elisa Conficoni, Simone Grotti, Daniela Valpiani, Giovanni Poletti, Gianni Dall'Ara, Roberto Carletti
Publikováno v:
Seminars in Thrombosis and Hemostasis. 47:102-104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e440f3dc09540ee0d39ee8fdf3b70790
https://doi.org/10.1055/s-0040-1718871
https://doi.org/10.1055/s-0040-1718871
A model of an inflammatory bowel disease population-based registry: The Forlì experience (1993–2013)
Autor:
Lauro Bucchi, Marina Mercuriali, E. Ricci, Alessandra Ravaioli, Daniela Valpiani, Orietta Giuliani, Fabio Falcini, Americo Colamartini, I. Manzi
Publikováno v:
Digestive and Liver Disease. 50:32-36
Background and aims The article presents a population-based registry designed to estimate incidence and prevalence of inflammatory bowel disease (IBD) in the area of Forli (north-eastern Italy). Methods The registry included all patients with IBD ulc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4985a58ce8c5e4a743007d7ce424f0d6
https://doi.org/10.1016/j.dld.2017.09.120
https://doi.org/10.1016/j.dld.2017.09.120
Autor:
Gionata Fiorino, Flavio Caprioli, Marco Daperno, Filippo Mocciaro, Mariabeatrice Principi, Angelo Viscido, Massimo Claudio Fantini, Ambrogio Orlando, Claudio Papi, Vito Annese, Silvio Danese, Maurizio Vecchi, Fernando Rizzello, Alessandro Armuzzi, Salvatore Leone, Enrica Previtali, Marina Aloi, Patrizia Alvisi, Elisabetta Antonelli, Sandro Ardizzone, Marco Astegiano, Monia Baldoni, Marina Beltrami, Livia Biancone, Giorgia Bodini, Andrea Buda, Fabrizio Bossa, Fiammetta Bracci, Emma Calabrese, Maria Cappello, Fabiana Castiglione, Carolina Ciacci, Michele Cicala, Rachele Ciccocioppo, Michele Comberlato, Claudio Camillo Cortelezzi, Rocco Cosintino, Francesco Costa, Giuseppe Costantino, Salvatore Cucchiara, Antonio Cuomo, Renata D’Incà, Maria Carla Di Paolo, Antonio Di Sabatino, Antonio Di Sario, Giuseppe Frieri, Walter Fries, Antonio Gasbarrini, Andrea Geccherle, Paolo Gionchetti, Maria Giovanna Graziani, Laurino Grossi, Luisa Guidi, Gianni Imperiali, Giovanni Latella, Paolo Lionetti, Gaetano Inserra, Giovanni Maconi, Francesco Manguso, Marco Marino, Mauro Mastronardi, Silvia Mazzuoli, Gianmichele Meucci, Marco Mendolaro, Monica Milla, Giammarco Mocci, Giovanni Monteleone, Francesco Neri Bortoluzzi, Cristiano Pagnini, Luca Pastorelli, Roberta Pica, Simona Piergallini, Antonello Privitera, Sara Renna, Davide Giuseppe Ribaldone, Chiara Ricci, Antonio Rispo, Rodolfo Rocca, Claudio Romano, Marco Romano, Giovanni Russo, Renato Sablich, Simone Saibeni, Edoardo Savarino, Maria Lia Scribano, Rocco Spagnuolo, Elisa Stasi, Maria Maddalena Terpin, Anna Testa, Daniela Valpiani, Angela Variola, Piero Vernia, Giovanna Vitale, Giorgio Zoli
The first infliximab biosimilar for the treatment of inflammatory bowel disease (IBD) was introduced in 2013, and today eight anti-TNF alpha biosimilars (three for infliximab and five for adalimumab) have been approved and licensed by the European Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075b5cf361561eee8b6822cb44f35fe5
Autor:
Federico Miglio, Daniela Valpiani, Salvatore Ricca Rossellini, Antonella Ferrieri, Nadia Canova
Publikováno v:
Current medical research and opinion. 13(10)
The aim of this study was to evaluate the efficacy and tolerability of rifaximin, a non-absorbable intestinal antibiotic, in comparison to neomycin in the short- and long-term treatment of hepatic encephalopathy (HE). Forty-nine patients with a defin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3256aeb891e2600fa8f5142f60da34
https://pubmed.ncbi.nlm.nih.gov/9327194
https://pubmed.ncbi.nlm.nih.gov/9327194